Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

The UK-PSCSC Consortium, Liu, Jimmy Z, The International IBD Genetics Consortium, The International PSC Study Group, Hov, Johannes Roksund, Folseraas, Trine, Ellinghaus, Eva, Rushbrook, Simon M +79 more·2013·Nature Genetics
DOI 10.1038/ng.2616

Cited by (392)

Items 301–392 of 392

  1. Genetic Predisposition, Humans
    Margaret A. Jordan, Alan G. Baxter · 2019 · Elsevier eBooks
  2. Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease
    Haruka Okada, Shinya Sugimoto, Atsuto Kayashima, Yohei Mikami, Takanori Kanai∥, Nobuhiro Nakamoto, Keio PSC–IBD Collaborators, Yusuke Yoshimatsu, Hiroki Kiyohara, Yukie Nakadai et al. · 2026 · Journal of Gastroenterology
  3. The genetic architecture of bipolar disorder: Entering the road of discoveries
    Olav Bjerkehagen Smeland, Andreas J. Forstner, Alexander W. Charney, Eli A. Stahl, Ole A. Andreassen · 2019 · Elsevier eBooks
  4. Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary function
    Xavier Farré, Roderic Espín, Alexandra Baiges, Eline Blommaert, Wonji Kim, Krinio Giannikou, Carmen Herranz, Antonio Román, Berta Sáez, Álvaro Casanova et al. · 2021 · ERJ Open Research
  5. Recent Insights into Pediatric Primary Sclerosing Cholangitis
    James P. Stevens, Nitika Arora Gupta · 2022 · Clinics in Liver Disease
  6. Association between regulatory T cells and ischemic heart disease: a Mendelian randomization study
    Yucheng Hou, Ke Si, Jingyue Yang, Tan Liu, Basel Abdelazeem, Nonthikorn Theerasuwipakorn, Jingwei Zhao, Zhenya Shen · 2024 · Journal of Thoracic Disease
  7. Intergenic risk variant rs56258221 skews the fate of naive CD4+ T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis
    Tobias Poch, Jonas Bahn, Christian Casar, Jenny Krause, Ioannis Evangelakos, Hilla Giladi, Lilly Kunzmann, Alena Laschtowitz, Nicola Iuso, Anne-Marie Schäfer et al. · 2024 · Cell Reports Medicine
  8. Phenotype‐informed polygenic risk scores are associated with worse outcome in individuals at risk of Alzheimer's disease
    Kaja Nordengen, Lene Pålhaugen, Francesco Bettella, Shahram Bahrami, Per Selnes, Jonas Alexander Jarholm, Lavinia Athanasiu, Alexey A. Shadrin, Ole A. Andreassen, Tormod Fladby · 2022 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  9. Primary sclerosing cholangitis: One disease or several?
    Christopher L. Bowlus · 2014 · Clinical Liver Disease
  10. Immunology of Primary Sclerosing Cholangitis
    John M. Vierling · 2016 · Springer eBooks
  11. Primary Sclerosing Cholangitis
    Roger William Chapman, Kate D. Williamson · 2017 · Technical report
  12. Search for Genetic Modifiers of PSC: Time to Increase the Number of Needles in the Haystack
    Marcin Jan Krawczyk, Frank Lammert · 2017 · Annals of Hepatology
  13. Primary and Secondary Sclerosing Cholangitis
    Christopher L. Bowlus, David N. Assis, David Goldberg · 2018 · Elsevier eBooks
  14. Primary Sclerosing Cholangitis
    Laura Cristoferi, Alessio Gerussi, Marco Carbone, Pietro Invernizzi · 2021 · Springer eBooks
  15. Primary Sclerosing Cholangitis
    Alberto Quaglia · 2018 · Elsevier eBooks
  16. Bioinformatics analysis reveals shared molecular pathways for relationship between ulcerative colitis and primary sclerosing cholangitis
    Pooya Jalali, Malihe Rezaee, Alireza Yaghoobi, Moein Piroozkhah, Mohammad Reza Zabihi, Shahram Aliyari, Zahra Salehi · 2025 · Genomics & Informatics
  17. Macrophage signaling associates with fibrogenic program activation in periductal fibroblasts in pediatric primary sclerosing cholangitis
    Yunguan Wang, David Adeleke, Xiangfei Xie, Zi F. Yang, Xiangya Wang, Giulia Loi, Annika Yang vom Hofe, Manavi Singh, Astha Malik, Ramesh Kudira et al. · 2026 · JCI Insight
  18. Primary Sclerosing Cholangitis
    Christopher L. Bowlus · 2017 · Elsevier eBooks
  19. The causal impact of genetically predicted inflammatory bowel disease on extraintestinal manifestations: a mendelian randomization study
    Xingcan Fan, Anqi He, Kaiyu Li, Maorun Zhang, Qi Zhang, Wanyi Xiao, Gang Liu · 2025 · BMC Gastroenterology
  20. The Pathogenesis of Autoimmune Liver Diseases
    Alexander J. Kovalic, Herbert L. Bonkovsky · 2020 · Springer eBooks
  21. Primary Biliary Cholangitis
    Atsushi Tanaka, Patrick S.C. Leung, Christopher L. Bowlus, Merrill Eric Gershwin · 2020 · Springer eBooks
  22. The value of serum CA19‐9 in predicting primary sclerosing cholangitis in patients with ulcerative colitis
    Kourosh Masnadi Shirazi, Yasaman Hosseinzadeh, Zahra Nourpanah, Arman Masnadi Shirazi, Zeinab Nikniaz · 2019 · Advances in digestive medicine
  23. Primary Sclerosing Cholangitis
    Meredith A. Borman, Bertus Eksteen · 2014 · Clinical gastroenterology
  24. Editorial: dietary interventions to understand and treat primary sclerosing cholangitis—is gluten‐free diet a starting point?
    Johannes R. Hov · 2022 · Alimentary Pharmacology & Therapeutics
  25. Primary Sclerosing Cholangitis: Gender Effects in Valencia’s Low-Prevalence Region
    Alejandro Mínguez, Isabel Conde, Cristina Montón, Lara González González, Sonia Pascual, María Dolores Antón, Antonio Palau, Ana Forés, Concha Gisbert, Asunción Ojeda et al. · 2024 · Digestive Diseases and Sciences
  26. Primary sclerosing cholangitis and IgG4-associated cholangitis
    Christopher L. Bowlus · 2024 · Elsevier eBooks
  27. Comparable Long-Term Liver Transplant Outcomes in Primary Sclerosing Cholangitis with and without MASLD: Last Decade Analysis of the UNOS Database
    Leandro Sierra, Natchaya Polpichai, Nazlı Begüm Öztürk, Lynette M. Sequeira, Eleazar Enrique. Montalvan-Sanchez, Nikki K. Duong · 2025 · Digestive Diseases
  28. Integrative multi-omics and causal inference unveil novel therapeutic targets for primary sclerosing cholangitis and its genetic comorbidity with inflammatory bowel disease
    Wan‐Zhe Liao, Haobin Zhou, Zhuofeng Wen, Wenpeng Liang, Chongde Pan, Zhiyi Zhou, Jingzhang Sun, Chang Liu, Xiangdong Zhou, Qi Li et al. · 2025 · npj gut and liver.
  29. An epithelial GPR35 isoform supports tumor‐associated transcriptional and metabolic phenotypes
    Jørgen D. Rønneberg, Martine Hjeltnes, Josephine Krieger, Joshua E. Elias, Maria Stensland, Kristian Holm, Xiaojun Jiang, Chuki Khangsar, Tuula A. Nyman, Arthur Kaser et al. · 2026 · FEBS Letters
  30. Genetics of Primary Sclerosing Cholangitis
    Tom H. Karlsen, Gideon Morris Hirschfield · 2016 · Springer eBooks
  31. Autoimmune Hepatitis and Immune-Mediated Cholestatic Liver Diseases
    Albert J. Czaja · 2018 · Springer eBooks
  32. Genetics of bipolar disorder
    Kevin Sean O’Connell, Olav Bjerkehagen Smeland, Ole A. Andreassen · 2022 · Elsevier eBooks
  33. Primary Sclerosing Cholangitis
    Sharonjeet Sangha, Christopher L. Bowlus · 2008 · Humana Press eBooks
  34. Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease
    Blair P. Fennimore, Emilie H. Regner, Mark E. Gerich · 2016 · Springer eBooks
  35. Genetics of Multiple Sclerosis
    Ahmad Abdulaziz Abulaban, David A. Hafler, Erin E. Longbrake · 2019 · Royal Society of Chemistry eBooks
  36. Primary Sclerosing Cholangitis
    Nora V. Bergasa · 2021 · Springer eBooks
  37. The HVEM-BTLA Immune Checkpoint Restrains Murine Chronic Cholestatic Liver Injury by Regulating the Gut Microbiota
    Yanbo Kou, Xingping Zheng, Liyuan Meng, Mengnan Liu, Shihong Xu, Qiyue Jing, Shenghan Zhang, Hanying Wang, Jinzhi Han, Zhuanzhuan Liu et al. · 2022 · Frontiers in Immunology
  38. Primary Sclerosing Cholangitis
    Christopher L. Bowlus · 2020 · Springer eBooks
  39. Genetic susceptibility for inflammatory bowel disease across ethnicities and diseases
    Suzanne van Sommeren · 2019
  40. Inflammatory Bowel Disease, Celiac Disease, and Primary Sclerosing Cholangitis: Is There a Link?
    Chung Sang Tse, Parakkal Deepak, Kostintinos Papadakis · 2020 · Gastroenterology
  41. Sclerosing Cholangitis
    Tom H. Karlsen, Kirsten Muri Boberg · 2018 · Wiley eBooks
  42. Study of Risk Factors Associated With Recurrent Primary Sclerosing Cholangitis After Liver Transplantation in Shiraz >From 2011 to 2021.
    Seyed Alireza Taghavi, Ali Reza Safarpour, Sulmaz Ghahramani, Somayeh Mortazavi Moghadam, Iraj Shahramian, Gholam Reza Sivandzadeh, Saman Nikeghbalian, Masoud Tahani, Samira Saeian, Seyed Ali Malek‐Hosseini · 2024 · Experimental and Clinical Transplantation
  43. Autoimmune liver diseases: internist’s guide from bench to bedside
    Mario Visconti · 2015 · Italian Journal of Medicine
  44. High density mapping of the MHC reveals a common role for HLA- DRB1*01:03 in IBD and heterozygous advantage in ulcerative colitis
    Philippe Goyette, Gabrielle Boucher, Dermot Henry Mallon, Eva Ellinghaus, Luke Jostins, Hailiang Huang, Stephan Ripke, Elena S. Gusareva, Vito Annese, Stephen L. Hauser et al. · 2014
  45. BASIC AND TRANSLATIONAL—LIVER Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1
    Ynto S. de Boer, Nicole M. F. van Gerven, Antonie Zwiers, Bart J. Verwer, Bart van Hoek, Karel J. van Erpecum, Ulrich H. Beuers, Henk R. van Buuren, Joost P.H. Drenth, Jannie W. den Ouden et al. · 2014
  46. Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation
    Phunchai Charatcharoenwitthaya, Keith D. Lindor · 2015 · Springer eBooks
  47. Inflammatory Bowel Disease in Primary Sclerosing Cholangitis: Clinical Characteristics in Liver Transplanted and Non-Transplanted Patients
    Kristin Kaasen Jørgensen · 2013 · NORA - Norwegian Open Research Archives
  48. Klinische Genetik der Gallenwegserkrankungen
    M. Reichert, F. Lammert, Christoph Jüngst · 2016 · Die Gastroenterologie
  49. Genetics of Fibroinflammatory Disorders
    Davide Martorana, Francesco Bonatti, Javier J. Martin · 2017 · Rare diseases of the immune system
  50. Primary Sclerosing Cholangitis (PSC): Current Concepts in Biology and Strategies for New Therapy
    Palak Jitendrakumar Trivedi, Tom H. Karlsen · 2017 · Springer eBooks
  51. Bile Acids and Cholestatic Liver Disease 2: Primary Sclerosing Cholangitis
    Takahiro Nakazawa · 2017 · Springer eBooks
  52. Primary Sclerosing Cholangitis from Childhood to Adult Age : Risk Factors, Monitoring and Outcome
    Andrea Tenca · 2017 · Työväentutkimus Vuosikirja
  53. Le malattie infiammatorie immuno-mediate (IMID) di interesse internistico: fisiopatologia, aspetti clinici e prospettive di terapia
    Andrea Fontanella, Roberto Nardi, M. Masina, Generoso Uomo · 2017 · Italian Journal of Medicine
  54. Gastrointestinal and Hepatic Manifestations of Specific Genetic Disorders
    Judy H. Cho · 2015 · Wiley eBooks
  55. Biliary strictures in primary sclerosing cholangitis : aspects on inflammation and malignancy
    Erik von Seth · 2018 · Figshare
  56. Sepsis like a severe complication of autoimmune liver disease in gastroenterological patients
    A. A. Yakushev, И. Г. Федоров, L. Yu. Ilchenko, S. S. Shmycova, S. A. Rautbard, S. U. Orlov, Igor Gennadievich Nikitin, A. V. Salicov · 2019 · The Russian Archives of Internal Medicine
  57. Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis, and Autoimmune Hepatitis
    David González‐Serna, Martin Kerick, Javier J. Martin · 2019 · Rare diseases of the immune system
  58. IBD Genomic Risk Loci and Overlap with Other Inflammatory Diseases
    Fatemeh Hadizadeh, Charlie W. Lees, Catherine Labbé, John David Rioux, Miles Parkes, Alexandra Zhernakova, André Franke, Charlotte R H Hedin, Mauro D’Amato · 2019 · Springer eBooks
  59. Clinical Genetics of Cholangiopathies
    Matthias Reichert, Frank Lammert · 2020 · Encyclopedia of Life Sciences
  60. Genetics and Risk of Autoimmune Liver Diseases
    George F. Mells · 2020
  61. Sclerosing Cholangitis in Children
    William F. Balistreri, Simon Lam · 2021 · Cambridge University Press eBooks
  62. Cholangiocarcinoma Surveillance in Primary Sclerosing Cholangitis and IgG4-Related Sclerosing Cholangitis
    Ahmad Hassan Ali, Elizabeth J. Carey · 2021 · Springer eBooks
  63. Charakterisierung immunpathogenetischer Mechanismen der Primär Sklerosierenden Cholangitis
    Tanja Schoknecht · 2015
  64. Faculty Opinions recommendation of Resolving mechanisms of immune-mediated disease in primary CD4 T cells.
    Salvatore Spicuglia · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  65. Challenges for diagnosis and treatment of primary biliary cholangitis
    Atsushi Tanaka · 2023 · Elsevier eBooks
  66. Finding the TRAIL to escape granzyme B–mediated liver injury in PSC
    Maria Eugenia Guicciardi, Nidhi Jalan‐Sakrikar · 2024 · Hepatology
  67. Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis
    Jessica Leighton, David E. Jones, Jessica Katharine Dyson, Heather Jane Cordell · 2024 · BMC Medical Genomics
  68. Protein Level Ratios as Causal Factors in Primary Sclerosing Cholangitis: Insights from a Two-Sample Mendelian Randomization Study
    Jie Zhou, Yixin Xu, Haitao Wang, Kun Wang, Chao Chen · 2024 · Research Square
  69. Cumulative Evidence on Associations between Genetic Variants and Autoimmune Hepatitis
    Dongqing Gu, Yizhou Wang, Liang Ge, Min Zhang · 2024 · Journal of Biosciences and Medicines
  70. Shared genetic architecture between leukocyte telomere length and Alzheimer’s disease
    Zhi Ping Cao, Qilong Tan, Hongxi Yang, Chenjie Xu · 2025 · Alzheimer s Research & Therapy
  71. Current problems of sclerosing cholangitis in children
    Волынец Галина Васильевна, А. С. Потапов, Анатолий Ильич Хавкин, Artem V. Nikitin, Скворцова Тамара Андреевна · 2024 · Экспериментальная и клиническая гастроэнтерология
  72. UŽDEGIMINĖS ŽARNŲ LIGOS ASOCIACIJA SU PIRMINIU SKLEROZUOJANČIU CHOLANGITU: PAGRINDINIS PATOGENEZINIS RYŠYS
    Domantas Jakubauskas, Aistis Lemežis · 2025 · Health Sciences
  73. Bidirectional causal links between diabetes mellitus and autoimmune liver diseases: Insights from Mendelian randomization
    Haixia Kuang, Jian Wu, Tao Huang, Kai Yan, Xiao-Yun Hu, Ying Wu, Yudi Wang, Zhihong Wu, Xiao Chen, G. Yuan · 2025 · Journal of Diabetes Investigation
  74. Macrophages drive a fibrogenic gene program of periductal fibroblasts in pediatric primary sclerosing cholangitis
    Yunguan Wang, David Adeleke, Xiangfei Xie, Zi F. Yang, Annika Yang vom Hofe, Manavi Singh, Astha Malik, Ramesh Kudira, Cyd M. Castro-Rojas, Liva Pfuhler et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Causal mediation of immune cells in autoimmune liver diseases and oral cancer risk: a Mendelian randomization study
    Shen‐sui Li, Weili Wang, Xudong Tian, Qiong Gao, Ya-Dong Wu, Jukun Song, Zhenglong Tang · 2025 · International Journal of Surgery
  76. Additional file 1 of Epigenomic analysis reveals a dynamic and context-specific macrophage enhancer landscape associated with innate immune activation and tolerance
    Zhang, Ping, Harindra Eranthi Amarasinghe, Justin P. Whalley, Chwen Tay, Fang, Hai, Gabriele Migliorini, Andrew Brown, Alice Allcock, Giuseppe Scozzafava, Phalguni Rath et al. · 2022 · Figshare
  77. Additional file 3 of Epigenomic analysis reveals a dynamic and context-specific macrophage enhancer landscape associated with innate immune activation and tolerance
    Zhang, Ping, Harindra Eranthi Amarasinghe, Justin P. Whalley, Chwen Tay, Fang, Hai, Gabriele Migliorini, Andrew Brown, Alice Allcock, Giuseppe Scozzafava, Phalguni Rath et al. · 2022 · Figshare
  78. Additional file 2 of Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis
    Jessica Leighton, Jones, David E. J., Jessica Katharine Dyson, Cordell, Heather J. · 2024 · Figshare
  79. Additional file 3 of Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis
    Jessica Leighton, Jones, David E. J., Jessica Katharine Dyson, Cordell, Heather J. · 2024 · Figshare
  80. Additional file 1 of ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitis
    Zhang, Jian, Huiwen Wang, Jinqing Liu, Fu, Lei, Shifang Peng · 2023 · Figshare
  81. Additional file 1 of Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis
    Jessica Leighton, Jones, David E. J., Jessica Katharine Dyson, Cordell, Heather J. · 2024 · Figshare
  82. Proteome-scale autoantibody profiling in PSC: Associations with clinical phenotypes and evidence for neuroendocrine deregulations
    Martin Cornillet, Aiva Lundberg Båve, Dan Sun, Ghada Nouaïria, Christina Villard, Aristeidis Grigoriadis, Erik von Seth, Hannes Jansson, María Bueno Álvez, Sofia Bergström et al. · 2025 · JHEP Reports
  83. Genotype–phenotype interaction in Alzheimer's disease immune activation
    Stephanie Lindgård Knudtzon, Bjørn‐Eivind Kirsebom, Lene Pålhaugen, Francesco Bettella, Berglind Gísladóttir, Shahram Bahrami, Lavinia Athanasiu, Arvid Rongve, Arne Exner Nakling, Ina S. Almdahl et al. · 2026 · Alzheimer s & Dementia
  84. Conserved Ductular Reaction Mechanisms in Biliary Atresia and Primary Sclerosing Cholangitis Derived From Single-Cell and Spatial Transcriptomics
    Annabelle Schofield, BM Kamath, Sonya A. MacParland, Michael Trauner, Palak Trivedi, JP Mann · 2026 · Cellular and Molecular Gastroenterology and Hepatology
  85. Research trends on autoimmune liver diseases and gut microbiota (1989–2025): a bibliometric and visualization analysis based on the web of science core collection database
    Ying Wan, Mengyao Zheng, Wen Fu, Huiling Zhu, Yuting Li, Huiying Lin, Jie Chen, Jianwei Li, Qiulan Mo, Wenlin Tai et al. · 2026 · Frontiers in Immunology
  86. Epidemiology, Risk Factors and Pathophysiology of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease: An Update
    Luisa Bertin, Paul Henderson, Richard Charles G Pollok, Natália Queiroz, Luca Fabris, Edoardo Vincenzo Savarino, Iago Rodríguez-Lago, Brigida Barberio · 2026 · JCC Plus
  87. Divergent effects of HLA-DQA1:p.Gln198Glu on trajectory in inflammatory bowel disease
    Laura Fachal, Benjamin Zaré, Mohmmed Tauseef Sharip, Nicola J Wyatt, Christopher Roberts, Qian Zhang, Eathar Shakweh, Jennifer Clough, NIHR IBD BioResource group, Jack Satsangi et al. · 2026 · Research Square
  88. Genetic markers of polycystic ovarian syndrome: A descriptive review
    A. Folorunsho Ajayi, V. Amos, Aduragbemi Hezekiah Ayodele, W. Adeyemi, L. Oluwatoyin Ajayi, O. Oyeniran · 2026 · Clínica e Investigación en Ginecología y Obstetricia
  89. Long-range regulatory target prediction reveals shared genetic background across ulcerative colitis, Crohn’s disease, primary sclerosing cholangitis and ankylosing spondylitis
    Dorian Dulcic, Katarina Mandić, Dalibor Hršak, Anja Barešić · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  90. Epidemiology of primary sclerosing cholangitis in general and IBD populations: a systematic review and meta-analysis
    Glenn Jun Kit Ho, Asvin Selvakumar, L L L Yeo, Mako Eguchi, Ryan Yanzhe Lim, Benedix Sim, Daniel Tung, Apoorva N Sasikumar, Shirley Huey Shin Bong, Ethan Kai Jun Tham et al. · 2026 · Hepatology International
  91. Temporal assessment of spatial and single-cell transcriptomes identifies CD226-NECTIN2 T cell-cholangiocyte interaction in bile duct inflammation
    Markus Sebastian Jördens, Kathrine Sivertsen Nordhus, Jonas Øgaard, Enya Amundsen-Isaksen, Oda Helgesen Ramberg, Wen Jie Yeoh, Kristian Holm, Xiaojun Jiang, Tom Luedde, Tom H. Karlsen et al. · 2026 · Journal of Hepatology
  92. Microbial products trigger chemosensory dialogues through intestinal G protein-coupled receptors
    Motohiko Kadoki, コウサク ナンキ, Dávid Szamosvári, Ahmed M.T. Mohamed, Martin Stražar, Kumar Thurimella, 이정호, Shin Yern-Hyerk, Panhasith Ung, Menglei Shuai et al. · 2026 · Cell Host & Microbe